These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 29150054)
21. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Harrison MS; Eckert LO; Cutland C; Gravett M; Harper DM; McClure EM; Nunes AP; Lazo S; Moore TM; Watson W; Kochhar S; Goldenberg RL; Vaccine; 2016 Dec; 34(49):6093-6101. PubMed ID: 27491689 [No Abstract] [Full Text] [Related]
22. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Wise RP; Bonhoeffer J; Beeler J; Donato H; Downie P; Matthews D; Pool V; Riise-Bergsaker M; Tapiainen T; Varricchio F; Vaccine; 2007 Aug; 25(31):5717-24. PubMed ID: 17493712 [No Abstract] [Full Text] [Related]
23. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K; Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552 [No Abstract] [Full Text] [Related]
24. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I; Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484 [No Abstract] [Full Text] [Related]
25. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Marcy SM; Kohl KS; Dagan R; Nalin D; Blum M; Jones MC; Hansen J; Labadie J; Lee L; Martin BL; O'Brien K; Rothstein E; Vermeer P; Vaccine; 2004 Jan; 22(5-6):551-6. PubMed ID: 14741143 [No Abstract] [Full Text] [Related]
26. Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Wenger P; Oleske JM; Kohl KS; Fisher MC; Brien JH; Graham PL; LaRussa PS; Lipton S; Tierney B; Vaccine; 2007 Aug; 25(31):5754-62. PubMed ID: 17537553 [No Abstract] [Full Text] [Related]
27. Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data. Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; Trolin I; Norton SA; Neff JM; Vaccine; 2007 Aug; 25(31):5725-34. PubMed ID: 17532547 [No Abstract] [Full Text] [Related]
28. Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Kohl KS; Ball L; Gidudu J; Hammer SJ; Halperin S; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2007 Aug; 25(31):5821-38. PubMed ID: 17540485 [No Abstract] [Full Text] [Related]
29. Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Halperin S; Kohl KS; Gidudu J; Ball L; Hammer SJ; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2007 Aug; 25(31):5803-20. PubMed ID: 17548135 [No Abstract] [Full Text] [Related]
30. Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Jones JF; Kohl KS; Ahmadipour N; Bleijenberg G; Buchwald D; Evengard B; Jason LA; Klimas NG; Lloyd A; McCleary K; Oleske JM; White PD; Vaccine; 2007 Aug; 25(31):5685-96. PubMed ID: 17400340 [No Abstract] [Full Text] [Related]
31. Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Bonhoeffer J; Vermeer P; Halperin S; Kempe A; Music S; Shindman J; Walop W; Vaccine; 2004 Jan; 22(5-6):586-91. PubMed ID: 14741148 [No Abstract] [Full Text] [Related]
32. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Varricchio F; Rothstein E; Schuind A; Hennig R; Vaccine; 2007 Aug; 25(31):5858-74. PubMed ID: 17548132 [No Abstract] [Full Text] [Related]
33. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Hennig R; Rothstein E; Schuind A; Varricchio F; Vaccine; 2007 Aug; 25(31):5839-57. PubMed ID: 17553602 [No Abstract] [Full Text] [Related]
34. Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Beigel J; Kohl KS; Khuri-Bulos N; Bravo L; Nell P; Marcy SM; Warschaw K; Ong-Lim A; Poerschke G; Weston W; Lindstrom JA; Stoltman G; Maurer T; Vaccine; 2007 Aug; 25(31):5697-706. PubMed ID: 17403561 [No Abstract] [Full Text] [Related]
35. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Bonhoeffer J; Menkes J; Gold MS; de Souza-Brito G; Fisher MC; Halsey N; Vermeer P; Vaccine; 2004 Jan; 22(5-6):557-62. PubMed ID: 14741144 [No Abstract] [Full Text] [Related]
36. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Rothstein E; Kohl KS; Ball L; Halperin SA; Halsey N; Hammer SJ; Heath PT; Hennig R; Kleppinger C; Labadie J; Varricchio F; Vermeer P; Walop W; Vaccine; 2004 Jan; 22(5-6):575-85. PubMed ID: 14741147 [No Abstract] [Full Text] [Related]
37. Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Bonhoeffer J; Gold MS; Heijbel H; Vermeer P; Blumberg D; Braun M; de Souza-Brito G; Davis RL; Halperin S; Heininger U; Khuri-Bulos N; Menkes J; Nokleby H; Vaccine; 2004 Jan; 22(5-6):563-8. PubMed ID: 14741145 [No Abstract] [Full Text] [Related]
38. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705 [TBL] [Abstract][Full Text] [Related]
39. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Tapiainen T; Prevots R; Izurieta HS; Abramson J; Bilynsky R; Bonhoeffer J; Bonnet MC; Center K; Galama J; Gillard P; Griot M; Hartmann K; Heininger U; Hudson M; Koller A; Khetsuriani N; Khuri-Bulos N; Marcy SM; Matulionyte R; Schöndorf I; Sejvar J; Steele R; Vaccine; 2007 Aug; 25(31):5793-802. PubMed ID: 17574313 [No Abstract] [Full Text] [Related]
40. Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Villagomez AN; Muñoz FM; Peterson RL; Colbert AM; Gladstone M; MacDonald B; Wilson R; Fairlie L; Gerner GJ; Patterson J; Boghossian NS; Burton VJ; Cortés M; Katikaneni LD; Larson JCG; Angulo AS; Joshi J; Nesin M; Padula MA; Kochhar S; Connery AK; Vaccine; 2019 Dec; 37(52):7623-7641. PubMed ID: 31783983 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]